May 16, 2024 | Featured, Maryland, News, Science
Bookmark (0) Please login to bookmarkClose Username or Email Address Password Remember Me PYC Therapeutics, an Australia-based developer of RNA therapies, reported initial results from its Phase 1 PLATYPUS clinical trial in the US for an RNA therapy known as VP-001...
May 14, 2024 | Featured, Maryland, News, Science
Bookmark (0) Please login to bookmarkClose Username or Email Address Password Remember Me A team of genetic researchers from the UK, US, and Switzerland has identified a mutation in the gene TMEM216 as a common cause of retinitis pigmentosa (RP) in people with African...
May 10, 2024 | Featured, Maryland, News, Science
Bookmark (0) Please login to bookmarkClose Username or Email Address Password Remember Me EyeDNA Therapeutics, a subsidiary of Paris-based Coave Therapeutics, reported encouraging 24-month results for 17 adult patients in its Phase ½ PDE6B gene therapy clinical trial...
Feb 21, 2024 | Featured, Maryland, News, Science
Bookmark (0) Please login to bookmarkClose Username or Email Address Password Remember Me The biotechnology company is preparing to launch a pivotal, Phase 3 clinical trial in the US for its emerging jCell therapy. The company’s announcement came after a successful...
Feb 9, 2024 | Featured, Maryland, News, Science
Bookmark (0) Please login to bookmarkClose Username or Email Address Password Remember Me Beacon Therapeutics has reported vision improvements for five of eight patients receiving the high dose of its X-linked retinitis pigmentosa (XLRP) gene therapy in the Phase 2...
Nov 8, 2023 | Featured, Maryland, News, Science
Bookmark (0) Please login to bookmarkClose Username or Email Address Password Remember Me Kiora Pharmaceuticals has announced some vision restoration for participants in ABACUS-1, its Phase ½ clinical trial in Australia for KIO-301, a molecule designed to bestow light...
